Delivery Order SPE2DB24D2216-SPE2DB25FGPNS
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 18, 2025, for the supply of Potassium Chloride Extended Release 10 MEQ tablets in quantities of 1,000 units, with a ceiling value of $5,993.44. This is a firm fixed price delivery order with an ultimate completion date of June 20, 2025, and represents a non-competitive set-aside award. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Potassium Chloride Extended Release 8 MEQ tablets in quantities of 500 units, with a contract ceiling value of $7,195.15. This is a firm fixed-price delivery order with an ultimate completion date of July 25, 2025, and represents a non-competitive set-aside award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the place of performance for...
- The Defense Logistics Agency awarded a delivery order valued at $7,946.59 to AmerisourceBergen Drug Corp for the supply of Potassium Chloride Extended-Release 10 MEQ tablets in quantities of 1,000 units. This is a firm fixed price, non-set-aside contract with an ultimate completion date of July 18, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $3,133.24 to AmerisourceBergen Drug Corp for Potassium Chloride Extended Release 10 MEQ tablets (500-count packaging). This was a competitively awarded, firm fixed-price delivery order with no set-aside designation, completed on April 24, 2025. The pharmaceutical products will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters and primary...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Potassium Chloride Extended Release 10 MEQ tablets in quantities of 1,000 units. This contract, valued at $22,252.80 with firm fixed pricing, is scheduled for completion by September 19, 2025, and represents a non-set-aside, competitively awarded procurement. The order will be fulfilled from AmerisourceBergen's Conshohocken, Pennsylvania facility, where the company...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Potassium Chloride Extended Release 20 MEQ tablets in quantities of 500, with a contract ceiling value of $4,934.88. This firm fixed-price delivery order, which has an ultimate completion date of August 15, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through...
- This delivery order, awarded on September 19, 2025, by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, provides $4,451.00 for the delivery of Potassium Chloride Extended Release 10 MEQ tablets in quantities of 1,000 units. The contract utilizes firm fixed pricing with no set-aside designation, indicating competitive award through open competition. Performance will be completed at AmerisourceBergen's Conshohocken, Pennsylvania facility, with an ultimate completion date of...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of Potassium Chloride Extended Release 10 milliequivalent tablets in quantities of 1,000 units, with a ceiling value of $1,326.38. This is a firm fixed-price delivery order with an ultimate completion date of July 15, 2025, and represents a competitive award with no set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,391.20 to AmerisourceBergen Drug Corp for Potassium Chloride Extended-Release 10 MEQ tablets in quantities of 1,000 units. This contract award, issued on June 24, 2025, with an ultimate completion date of June 25, 2025, represents a firm fixed price delivery order with no set-aside designation. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Potassium Chloride Extended-Release 8 MEQ tablets in quantities of 500 tablets, with a contract ceiling value of $8,459.67. This non-set-aside, competitively awarded delivery order is structured as a firm fixed price contract and is scheduled for completion by August 15, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work...
- SPE2DB24D2216Indefinite Delivery Contract
- SPE2DB24D2216-SPE2DB25FGPNSDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,178.58 to AmerisourceBergen Drug Corp for the supply of Potassium Chloride Extended Release 10 MEQ tablets in quantities of 1,000 units. This firm fixed-price delivery order, awarded on August 14, 2025, with an ultimate completion date of August 15, 2025, represents a routine pharmaceutical procurement from the vendor's Conshohocken, Pennsylvania location. The contract was competitively awarded with no set-aside designation, reflecting AmerisourceBergen's established capability to meet federal medical supply requirements. This delivery order is issued under AmerisourceBergen Drug Corp's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive $999,999,999.00 global pharmaceutical support vehicle extending through December 2026. As a major pharmaceutical distributor and critical federal vendor, AmerisourceBergen serves the Defense Health Agency and other military healthcare systems through this prime contract vehicle, which enables flexible procurement of an extensive range of pharmaceutical products, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. The potassium chloride delivery order exemplifies the company's role in supporting routine pharmaceutical supply needs for military and federal health programs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 8/14/25 |